T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.35% |
| 2 | Healthcare | 16.19% |
| 3 | Consumer Discretionary | 15.55% |
| 4 | Financials | 12.84% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCPX
2576
DELISTED
Scorpius Holdings, Inc.
SCPX
| $279K | ﹤0.01% |
10
+5
| +100% | +$159K |
|
|
HOFV
2577
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
| $278K | ﹤0.01% |
+2,514
| New | +$152K |
|
2578
Immunovant
IMVT
$8.64B
| $277K | ﹤0.01% |
17,258
-272,730
| -94% | -$7.19M |
|
|
FFG
2579
DELISTED
FBL Financial Group
FFG
| $277K | ﹤0.01% |
4,952
+2
| +0% | +$113 |
|
|
KNL
2580
DELISTED
Knoll, Inc.
KNL
| $275K | ﹤0.01% |
16,634
-14,875
| -47% | -$243K |
|
2581
Mercer International
MERC
$33.8M
| $274K | ﹤0.01% |
19,007
-332
| -2% | -$4.42K |
|
2582
Kosmos Energy
KOS
$1.51B
| $273K | ﹤0.01% |
88,822
-5,319,628
| -98% | -$15.5M |
|
2583
SI-BONE Inc
SIBN
$849M
| $272K | ﹤0.01% |
8,543
-2,806
| -25% | -$86.3K |
|
|
CTO
2584
CTO Realty Growth
CTO
$823M
| $271K | ﹤0.01% |
15,654
-1,122
| -7% | -$18.2K |
|
2585
Leslie's
LESL
$7.21M
| $270K | ﹤0.01% |
+552
| New | +$282K |
|
|
VOXX
2586
DELISTED
VOXX International Corporation Class A
VOXX
| $270K | ﹤0.01% |
+14,147
| New | +$294K |
|
2587
Phibro Animal Health
PAHC
$1.38B
| $269K | ﹤0.01% |
11,013
-324,100
| -97% | -$7.32M |
|
2588
Anika Therapeutics
ANIK
$283M
| $265K | ﹤0.01% |
6,489
-17
| -0.3% | -$645 |
|
|
AIM
2589
AIM ImmunoTech
AIM
$7.17M
| $265K | ﹤0.01% |
1,169
| – | – |
|
|
NFBK
2590
DELISTED
Northfield Bancorp
NFBK
| $264K | ﹤0.01% |
16,554
-80
| -0.5% | -$1.13K |
|
|
ATHX
2591
DELISTED
Athersys, Inc. Common Stock
ATHX
| $264K | ﹤0.01% |
5,865
-587
| -9% | -$30.5K |
|
2592
Cenovus Energy
CVE
$56.4B
| $263K | ﹤0.01% |
35,024
| – | – |
|
2593
Geron
GERN
$982M
| $263K | ﹤0.01% |
166,175
-29,282
| -15% | -$52.3K |
|
2594
iShares MSCI KLD 400 Social ETF
DSI
$5.58B
| $260K | ﹤0.01% |
3,410
-250
| -7% | -$18.5K |
|
2595
VirnetX Holding Corp
VHC
$64.8M
| $260K | ﹤0.01% |
2,330
+344
| +17% | +$43.1K |
|
2596
ACM Research
ACMR
$5.65B
| $259K | ﹤0.01% |
9,600
-5,400
| -36% | -$179K |
|
2597
Citizens
CIA
$198M
| $258K | ﹤0.01% |
44,560
+298
| +0.7% | +$1.84K |
|
2598
Willis Lease Finance
WLFC
$1.15B
| $258K | ﹤0.01% |
+17,775
| New | +$206K |
|
|
SDC
2599
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $258K | ﹤0.01% |
25,000
+3,400
| +16% | +$40.3K |
|
2600
Standard BioTools
LAB
$294M
| $257K | ﹤0.01% |
56,872
-19,845
| -26% | -$109K |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.